Schwarme, Germany

Sven Jähnichen


 

Average Co-Inventor Count = 9.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Amsterdamn, NL (2015)
  • Amsterdam, NL (2015)
  • Schwarme, DE (2016 - 2017)

Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Sven Jähnichen

Introduction

Sven Jähnichen is an innovative inventor based in Schwarme, Germany. With a strong focus on biochemistry and molecular biology, he has made significant contributions to the development of therapeutic compounds. His research is primarily centered around amino acid sequences designed to interact with cellular receptors related to viruses and bacteria.

Latest Patents

Sven Jähnichen holds an impressive portfolio of four patents. His latest inventions include:

1. **Amino Acid Sequences Directed Against Cellular Receptors for Viruses and Bacteria**: This invention details amino acid sequences aimed at human cellular receptors, specifically targeting various viruses like HIV, HCV, and adenoviruses. This innovative approach may prevent human cell entry of these harmful pathogens.

2. **Amino Acid Sequences Directed Against GPCRs and Polypeptides for GPCR-Related Diseases**: This invention encompasses amino acid sequences designed against G-protein coupled receptors (GPCRs). It also explores methods for preparing these amino acids, as well as their potential therapeutic applications in treating GPCR-related diseases and disorders.

Career Highlights

Sven Jähnichen is currently associated with Ablynx N.V., a biotechnology company that specializes in therapeutic development. His work involves groundbreaking research aimed at developing novel treatments that target serious health issues related to viral infections and receptor-related conditions.

Collaborations

Throughout his career, Sven has collaborated with esteemed professionals such as Christophe Blanchetot and Martine Smit. These partnerships have fostered an environment of innovation and collective expertise in the field of biochemistry and therapeutic applications.

Conclusion

Sven Jähnichen exemplifies the spirit of innovation in the scientific community. His pioneering work on amino acid sequences has the potential to revolutionize the way we approach treatments for viral diseases and receptor-related disorders. As he continues his research, the contributions of such inventors remain crucial to advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…